Global Markets
Home›Global Markets›North America›How competition between Chinese and Indian firms could…
How competition between Chinese and Indian firms could reshape Africa’s drug markets
China is challenging India’s long-held dominance of the African market for antimalarial drugs in 12 of the continent’s hardest-hit countries, according to a new study. Last year, Chinese exports of antimalarial drugs reached US$89.3 million, nearly matching India’s US$89.6 million, according to Indian market research company Sol Gravitas. The gap has closed significantly since 2021, when Indian exports stood at US$121 million compared with US$62.6 million for China. Separately, the study...
← Newer storyAbby Choi trial so far: ex-father-in-law lied to rent village flat, b…Older story →Ethereum staking yield is losing to cash rates, so why are investors…
More like this
Global MarketsPower stock to buy: Despite almost 20% fall in 1 month, Deven Choksey Research sees 72% returns ahead - Do you own?
Global MarketsChina study suggests animal sacrifice may have been part of ancient Sanxingdui rituals